BioRestorative Therapies, Inc. 10-K filing
Filed 2026-03-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001493152-26-012925
- Form type
- 10-K
- CIK
- 0001505497
- Primary document
- https://www.sec.gov/Archives/edgar/data/1505497/000149315226012925/form10-k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioRestorative Therapies, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $359,700 | - | - |
| Cost Of Revenue | $23,844 | - | - |
| Gross Profit | $335,856 | - | - |
| Operating Income | $-15.6M | - | - |
| Net Income | $-14.2M | - | - |
| Eps Basic | -1.58 | - | - |
| Eps Diluted | -1.58 | - | - |
| Cash And Equivalents | $1.5M | - | - |
| Total Assets | $4.1M | - | - |
| Shareholders Equity | $356,744 | - | - |
| Operating Cash Flow | $-10.8M | - | - |
| Capital Expenditures | $116,069 | - | - |